(1 -> 3)-beta-D-glucan and mannan guided early termination of antifungal therapy in ICU patients: a prospective randomized intervention study (REDUCE-AM)

Erb T, Mihai S, Cipa F, Herbst L, Strauss R, Castellanos I, Lang K, Ganslmayer M, Willam C, Rath A, Diesch K, Held J (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Mycoses Wiley-Blackwell

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 18-18

Conference Proceedings Title: MYCOSES

Authors with CRIS profile

Richard Strauss Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Alvaro Ixchel Castellanos Department of Anaesthesiology Marion Ganslmayer Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Carsten Willam Department of Medicine 4 – Nephrology and Hypertension Anca Rath Lehrstuhl für Funktionelle und Klinische Anatomie Jürgen Held Institute of Microbiology – Clinical Microbiology, Immunology and Hygiene

How to cite

APA:

Erb, T., Mihai, S., Cipa, F., Herbst, L., Strauss, R., Castellanos, I.,... Held, J. (2020). (1 -> 3)-beta-D-glucan and mannan guided early termination of antifungal therapy in ICU patients: a prospective randomized intervention study (REDUCE-AM). In MYCOSES (pp. 18-18). HOBOKEN: WILEY.

MLA:

Erb, T., et al. "(1 -> 3)-beta-D-glucan and mannan guided early termination of antifungal therapy in ICU patients: a prospective randomized intervention study (REDUCE-AM)." Proceedings of the MYCOSES HOBOKEN: WILEY, 2020. 18-18.

BibTeX: Download